Literature DB >> 11116049

Fc-gamma receptor cross-linking by immune complexes induces matrix metalloproteinase-1 in U937 cells via mitogen-activated protein kinase.

Y Huang1, A J Fleming, S Wu, G Virella, M F Lopes-Virella.   

Abstract

Matrix metalloproteinase-1 (MMP-1) secreted by macrophages potentially contributes to plaque rupture. Because large quantities of immunoglobulin G and ICs (ICs), including low density lipoprotein-containing ICs (LDL-ICs), are present in atherosclerotic lesions, we examined the effect of LDL-ICs on macrophage MMP-1 expression. With the use of ICs prepared with human LDL and rabbit anti-LDL antiserum, our enzyme-linked immunosorbent assays and Northern blots showed that MMP-1 secretion and expression by U937 histiocytes were induced by LDL-ICs. Furthermore, our results showed that blocking of Fc-gamma receptor I and II (FcgammaRI and FcgammaRII) inhibited 70% and 55%, respectively, of the LDL-IC-induced secretion of MMP-1. Finally, our data showed that both PD98059, an inhibitor of the mitogen-activated protein kinase pathway, and Ro-31-2880, an inhibitor of protein kinase C, inhibited LDL-IC-stimulated MMP-1 secretion in a dose-dependent manner, with 96% and 95% inhibition, respectively, at the respective doses of 50 micromol/L and 80 nmol/L. In conclusion, this study demonstrated for the first time that LDL-ICs induce macrophage MMP-1 secretion by cocross-linking FcgammaRI and FcgammaRII and triggering a protein kinase C-dependent mitogen-activated protein kinase pathway. These results suggest that LDL-ICs and other ICs localized in atherosclerotic plaques may be potent stimulators for macrophage MMP-1 expression and may contribute to plaque rupture and acute coronary events.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11116049     DOI: 10.1161/01.atv.20.12.2533

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  10 in total

Review 1.  Atherogenesis and the humoral immune response to modified lipoproteins.

Authors:  Gabriel Virella; Maria F Lopes-Virella
Journal:  Atherosclerosis       Date:  2008-04-12       Impact factor: 5.162

2.  Reduced Atherosclerosis in apoE-inhibitory FcγRIIb-Deficient Mice Is Associated With Increased Anti-Inflammatory Responses by T Cells and Macrophages.

Authors:  Hang Pong Ng; Xinmei Zhu; Erin Y Harmon; Michelle R Lennartz; Shanmugam Nagarajan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-19       Impact factor: 8.311

Review 3.  Fcγ receptors and ligands and cardiovascular disease.

Authors:  Keiji Tanigaki; Nathan Sundgren; Amit Khera; Wanpen Vongpatanasin; Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2015-01-16       Impact factor: 17.367

4.  The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE(-/-) mice.

Authors:  Yanice V Mendez-Fernandez; Bonnie G Stevenson; Cody J Diehl; Nicole A Braun; Nekeithia S Wade; Roman Covarrubias; Sander van Leuven; Joseph L Witztum; Amy S Major
Journal:  Atherosclerosis       Date:  2010-10-20       Impact factor: 5.162

5.  Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III.

Authors:  Souzan A Abdelsamie; Yanchun Li; Yan Huang; Mi-Hye Lee; Richard L Klein; Gabriel Virella; Maria F Lopes-Virella
Journal:  Clin Immunol       Date:  2011-02-10       Impact factor: 3.969

6.  Up-regulation of matrix metalloproteinase-1 expression in U937 cells by low-density lipoprotein-containing immune complexes requires the activator protein-1 and the Ets motifs in the distal and the proximal promoter regions.

Authors:  Alejandro Maldonado; Bryan A Game; Lanxi Song; Yan Huang
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

Review 7.  Clinical significance of the humoral immune response to modified LDL.

Authors:  Maria F Lopes-Virella; Gabriel Virella
Journal:  Clin Immunol       Date:  2009-05-08       Impact factor: 3.969

8.  Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis.

Authors:  M Jeziorska; A Hassan; M I Mackness; D E Woolley; A B Tullo; G S Lucas; P N Durrington
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

9.  Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice.

Authors:  M L F Smook; M van Leeuwen; P Heeringa; J G M C Damoiseaux; R Theunissen; M J A P Daemen; E Lutgens; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2008-09-05       Impact factor: 4.330

10.  High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.

Authors:  Maria F Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; Timothy J Lyons; Alicia J Jenkins; Gabriel Virella
Journal:  Diabetes Care       Date:  2012-04-17       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.